Catalio Capital Management »

Boston Scientific Corporation shares owned by Catalio Capital Management

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Catalio Capital Management from 13F filings

Historical chart of Catalio Capital Management investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Catalio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Catalio Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $26M 263k 97.63

More positions owned by Catalio Capital Management

Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Bridgebio Pharma (BBIO)
Intuitive Surgical Com New (ISRG)
Ascendis Pharma A/s Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Dianthus Therapeutics (DNTH)
Boston Scientific Corporation (BSX)
Syndax Pharmaceuticals (SNDX)
Cytokinetics Com New (CYTK)
Natera (NTRA)
Regeneron Pharmaceuticals (REGN)
Structure Therapeutics Sponsored Ads (GPCR)
Uniqure Nv SHS (QURE)
Disc Medicine (IRON)

View all positions for Catalio Capital Management

Top funds holding Boston Scientific Corporation

BlackRock
Vanguard Group
FMR
State Street Corporation
PRIMECAP Management Company
Geode Capital Management
Jpmorgan Chase & Co
Capital World Investors
Morgan Stanley
Bollard
Invesco
Goldman Sachs Group
Wellington Management Company
Northern Trust
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Boston Scientific Corporation